Table 1.
Healthy donors (HD) and patients’ characteristics.
| HD | Primary HIV infection (PHI) | Untreated chronic HIV infection (UT-CHI) | ART-treated patients (ART-CHI) | |
|---|---|---|---|---|
| Number of individuals | 17 | 19 | 17 | 23 |
| Age | 45 (37–52) | 41 (30–49) | 40 (31–44) | 52 (40–57) |
| Sex F/M | 4/13 | 1/18 | 5/12 | 5/18 |
| HIV-1 RNA (log10/mL) | NA | 5.5 (4.7–6.5) | 4.2 (4–4.8) | <20 |
| Lymphocyte count (cells/mm3) | NA | 1,440 (774–2,392) | 2,207 (1,504–2,584) | 1,891 (1,665–2,380) |
| CD4 (%) | NA | 32 (22–38) | 24 (21–38.5) | 36 (29–42) |
| CD4 count (cells/mm3) | NA | 497 (292–570) | 494 (377–815) | 723 (602–863) |
| CD8 (%) | NA | 45 (31–58) | 48 (40.5–53) | 40 (35–43) |
| CD8 count (cells/mm3) | NA | 552 (364–1,170) | 956 (590–1,229) | 704 (542–993) |
| CD4/CD8 ratio | NA | 0.7 (0.4–1.3) | 0.6 (0.4–0.9) | 0.9 (0.7–1.1) |
| Individuals seropositive for CMV | 60% | 79% | 88.2% | 86.3% |
Data are expressed as median (interquartile ranges).
NA, not available.